OTC EpiPen? US FDA Open To Switching Epinephrine For Anaphylaxis

 
• By Michael McCaughan
  
FDA outlined the ‘challenges’ facing any potential switch but emphasized ‘we are very willing to work with interested sponsors.’
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards